Klin Monbl Augenheilkd 2021; 238(10): 1108-1112
DOI: 10.1055/a-1478-4248

New Antimycotics in the Pipeline – For Ophthalmology Too?

A Short Review Article in several languages: English | deutsch
Wolfgang J. Behrens-Baumann
Otto-von-Guericke-Universität Magdeburg, Emeritus, Universitätsaugenklinik, Deutschland
› Author Affiliations


Seven new antimycotics are presented that are at different points of development or approval. These substances are mainly first-in-class drugs. They are primarily developed for systemic administration. However, with the support of a pharmacist, the intravenous formulation may be used as eyedrops. In this short review, the activities of the substances against various fungal infections are described. After unsuccessful conventional therapy of fungal eye infections, one of these new substances might be suitable to cure the mycosis.

Publication History

Received: 06 February 2021

Accepted: 26 March 2021

Article published online:
01 July 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany